Adverse Event Reporting Flashcards
7 cards from real CLE practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Adverse Event Reporting flashcards as text
A CLE in private practice receives a report that a client's infant developed a severe allergic reaction after the mother ingested a probiotic supplement recommended during a lactation consult. What is the CLE's reporting obligation?
Answer: Voluntarily report the event to FDA CAERS and document the recommendation and outcome in client records
CLEs who recommend products that result in adverse events should voluntarily report to FDA CAERS and document thoroughly, even without a prescribing role.
Which outcome would prompt the HIGHEST priority adverse event report to the FDA regarding a breast pump?
Answer: An infant hospitalized for sepsis after milk expressed with a contaminated pump flange
Hospitalization or serious infection causally linked to device use represents a serious adverse event requiring the most urgent mandatory or voluntary FDA reporting.
A lactation educator participates in a root cause analysis (RCA) after a neonatal unit identifies a feeding device as contributing to a near-miss event. What role does adverse event reporting play in the RCA process?
Answer: Filed adverse event reports provide baseline safety signal data that enriches the RCA and supports regulatory notification
Adverse event reports and RCA are complementary; filed reports feed into FDA signal detection while the RCA drives internal process improvement.
Which population requires SPECIAL consideration when assessing the severity of a lactation-product adverse event for reporting purposes?
Answer: Preterm and medically fragile neonates who may experience disproportionate harm
Preterm and medically fragile neonates are at elevated risk for serious harm from device or product problems, warranting heightened vigilance and lower reporting thresholds.
After submitting a MedWatch report, a CLE receives a follow-up request from the FDA for additional information. What is the BEST response?
Answer: Provide the requested clinical details promptly while maintaining patient confidentiality protections
Cooperating with FDA follow-up requests by supplying additional clinical data strengthens the safety investigation while HIPAA protections for de-identified or authorized disclosures still apply.
A CLE discovers that a mother has been using a breast milk storage bag that was not specifically tested for BPA-free status and suspects the bag may have caused infant colic symptoms. Which statement BEST applies?
Answer: The CLE should document the product use, counsel the mother to discontinue, and consider filing a voluntary CAERS or MedWatch report
Even without confirmed chemical analysis, suspected product-related infant symptoms warrant documentation, product discontinuation, and voluntary FDA reporting.
When a CLE trains new staff on adverse event reporting, which analogy BEST explains why reporting near-misses—not just completed harms—is important?
Answer: Near-misses are early signals that allow system corrections before a serious injury occurs
Near-miss reporting is foundational to safety culture because patterns in near-misses predict future harm and enable preventive intervention before a serious adverse event occurs.